Insider Sell Alert: S Crone Sells Shares of C&F Financial Corp (CFFI)

Article's Main Image

On November 27, 2024, S Crone, President & CEO of C&F Finance, executed a sale of 1,400 shares of C&F Financial Corp (CFFI, Financial). Following this transaction, the insider now holds 8,437 shares of the company. The details of this transaction can be found in the SEC Filing. C&F Financial Corp is a financial services company that provides a range of banking and related financial services to both individuals and businesses. The company operates through several segments, including retail banking, mortgage banking, and consumer finance. 1862617732672024576.png The insider transaction history for C&F Financial Corp indicates a trend of more insider sells than buys over the past year, with 3 insider buys and 8 insider sells. This recent sale by S Crone is part of this broader trend. 1862617814679056384.png On the day of the sale, shares of C&F Financial Corp were trading at $72.71, giving the stock a market cap of $232.133 million. The company's price-earnings ratio stands at 12.72, which is higher than the industry median of 10.87 and also higher than the company's historical median price-earnings ratio. The stock's GF Value is estimated at $55.95, resulting in a price-to-GF-Value ratio of 1.3. This suggests that the stock is modestly overvalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated using historical multiples, a GuruFocus adjustment factor, and future business performance estimates from Morningstar analysts.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.